| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005634 | nucleus | 5 | 1 |
| GO:0043226 | organelle | 2 | 1 |
| GO:0043227 | membrane-bounded organelle | 3 | 1 |
| GO:0043229 | intracellular organelle | 3 | 1 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3Q8ICX5
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
| GO:0006396 | RNA processing | 6 | 1 |
| GO:0006399 | tRNA metabolic process | 7 | 1 |
| GO:0006400 | tRNA modification | 6 | 1 |
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
| GO:0008033 | tRNA processing | 8 | 1 |
| GO:0008152 | metabolic process | 1 | 1 |
| GO:0009451 | RNA modification | 5 | 1 |
| GO:0009987 | cellular process | 1 | 1 |
| GO:0016070 | RNA metabolic process | 5 | 1 |
| GO:0034470 | ncRNA processing | 7 | 1 |
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
| GO:0034660 | ncRNA metabolic process | 6 | 1 |
| GO:0043170 | macromolecule metabolic process | 3 | 1 |
| GO:0043412 | macromolecule modification | 4 | 1 |
| GO:0044237 | cellular metabolic process | 2 | 1 |
| GO:0044238 | primary metabolic process | 2 | 1 |
| GO:0046483 | heterocycle metabolic process | 3 | 1 |
| GO:0061504 | cyclic threonylcarbamoyladenosine biosynthetic process | 7 | 1 |
| GO:0071704 | organic substance metabolic process | 2 | 1 |
| GO:0090304 | nucleic acid metabolic process | 4 | 1 |
| GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 11 |
| GO:0008641 | ubiquitin-like modifier activating enzyme activity | 2 | 11 |
| GO:0016874 | ligase activity | 2 | 11 |
| GO:0016877 | ligase activity, forming carbon-sulfur bonds | 3 | 11 |
| GO:0140096 | catalytic activity, acting on a protein | 2 | 11 |
| GO:0140657 | ATP-dependent activity | 1 | 11 |
| GO:0016829 | lyase activity | 2 | 1 |
| GO:0016835 | carbon-oxygen lyase activity | 3 | 1 |
| GO:0016836 | hydro-lyase activity | 4 | 1 |
| GO:0061503 | tRNA threonylcarbamoyladenosine dehydratase | 5 | 1 |
| GO:0140098 | catalytic activity, acting on RNA | 3 | 1 |
| GO:0140101 | catalytic activity, acting on a tRNA | 4 | 1 |
| GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 122 | 126 | PF00656 | 0.221 |
| CLV_C14_Caspase3-7 | 167 | 171 | PF00656 | 0.298 |
| CLV_NRD_NRD_1 | 180 | 182 | PF00675 | 0.324 |
| CLV_NRD_NRD_1 | 252 | 254 | PF00675 | 0.478 |
| CLV_NRD_NRD_1 | 257 | 259 | PF00675 | 0.463 |
| CLV_NRD_NRD_1 | 268 | 270 | PF00675 | 0.423 |
| CLV_NRD_NRD_1 | 85 | 87 | PF00675 | 0.290 |
| CLV_PCSK_FUR_1 | 253 | 257 | PF00082 | 0.535 |
| CLV_PCSK_KEX2_1 | 252 | 254 | PF00082 | 0.428 |
| CLV_PCSK_KEX2_1 | 255 | 257 | PF00082 | 0.425 |
| CLV_PCSK_KEX2_1 | 262 | 264 | PF00082 | 0.440 |
| CLV_PCSK_KEX2_1 | 267 | 269 | PF00082 | 0.425 |
| CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.254 |
| CLV_PCSK_PC1ET2_1 | 255 | 257 | PF00082 | 0.460 |
| CLV_PCSK_PC1ET2_1 | 262 | 264 | PF00082 | 0.476 |
| CLV_PCSK_PC1ET2_1 | 267 | 269 | PF00082 | 0.454 |
| CLV_PCSK_PC7_1 | 258 | 264 | PF00082 | 0.480 |
| CLV_PCSK_SKI1_1 | 130 | 134 | PF00082 | 0.235 |
| CLV_PCSK_SKI1_1 | 177 | 181 | PF00082 | 0.464 |
| CLV_PCSK_SKI1_1 | 262 | 266 | PF00082 | 0.506 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.451 |
| DEG_SPOP_SBC_1 | 58 | 62 | PF00917 | 0.311 |
| DOC_MAPK_gen_1 | 64 | 71 | PF00069 | 0.235 |
| DOC_USP7_MATH_1 | 144 | 148 | PF00917 | 0.254 |
| DOC_USP7_MATH_1 | 70 | 74 | PF00917 | 0.241 |
| DOC_USP7_UBL2_3 | 255 | 259 | PF12436 | 0.416 |
| DOC_USP7_UBL2_3 | 262 | 266 | PF12436 | 0.449 |
| DOC_WW_Pin1_4 | 269 | 274 | PF00397 | 0.626 |
| LIG_Actin_WH2_2 | 223 | 240 | PF00022 | 0.365 |
| LIG_Clathr_ClatBox_1 | 68 | 72 | PF01394 | 0.235 |
| LIG_FHA_1 | 126 | 132 | PF00498 | 0.279 |
| LIG_FHA_1 | 30 | 36 | PF00498 | 0.354 |
| LIG_FHA_1 | 8 | 14 | PF00498 | 0.312 |
| LIG_FHA_2 | 102 | 108 | PF00498 | 0.249 |
| LIG_FHA_2 | 165 | 171 | PF00498 | 0.297 |
| LIG_FHA_2 | 50 | 56 | PF00498 | 0.221 |
| LIG_LIR_Apic_2 | 220 | 226 | PF02991 | 0.265 |
| LIG_LIR_Nem_3 | 55 | 59 | PF02991 | 0.367 |
| LIG_MYND_1 | 201 | 205 | PF01753 | 0.460 |
| LIG_SH2_CRK | 117 | 121 | PF00017 | 0.183 |
| LIG_SH2_CRK | 223 | 227 | PF00017 | 0.244 |
| LIG_SH2_CRK | 56 | 60 | PF00017 | 0.367 |
| LIG_SH2_NCK_1 | 56 | 60 | PF00017 | 0.367 |
| LIG_SH2_STAP1 | 117 | 121 | PF00017 | 0.252 |
| LIG_SH3_2 | 202 | 207 | PF14604 | 0.440 |
| LIG_SH3_3 | 199 | 205 | PF00018 | 0.408 |
| LIG_Sin3_3 | 233 | 240 | PF02671 | 0.329 |
| LIG_SUMO_SIM_anti_2 | 189 | 197 | PF11976 | 0.366 |
| LIG_SUMO_SIM_anti_2 | 50 | 55 | PF11976 | 0.367 |
| LIG_SUMO_SIM_par_1 | 157 | 163 | PF11976 | 0.385 |
| LIG_SUMO_SIM_par_1 | 67 | 74 | PF11976 | 0.235 |
| LIG_SUMO_SIM_par_1 | 95 | 100 | PF11976 | 0.325 |
| LIG_TYR_ITIM | 54 | 59 | PF00017 | 0.279 |
| MOD_CK1_1 | 157 | 163 | PF00069 | 0.350 |
| MOD_CK2_1 | 75 | 81 | PF00069 | 0.284 |
| MOD_GlcNHglycan | 233 | 236 | PF01048 | 0.297 |
| MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.466 |
| MOD_GSK3_1 | 18 | 25 | PF00069 | 0.279 |
| MOD_GSK3_1 | 188 | 195 | PF00069 | 0.361 |
| MOD_GSK3_1 | 213 | 220 | PF00069 | 0.475 |
| MOD_GSK3_1 | 269 | 276 | PF00069 | 0.660 |
| MOD_GSK3_1 | 71 | 78 | PF00069 | 0.235 |
| MOD_N-GLC_1 | 217 | 222 | PF02516 | 0.358 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.484 |
| MOD_NEK2_1 | 217 | 222 | PF00069 | 0.416 |
| MOD_NEK2_1 | 22 | 27 | PF00069 | 0.367 |
| MOD_NEK2_1 | 231 | 236 | PF00069 | 0.215 |
| MOD_NEK2_1 | 29 | 34 | PF00069 | 0.357 |
| MOD_NEK2_1 | 71 | 76 | PF00069 | 0.221 |
| MOD_OFUCOSY | 123 | 129 | PF10250 | 0.279 |
| MOD_PIKK_1 | 7 | 13 | PF00454 | 0.345 |
| MOD_Plk_1 | 188 | 194 | PF00069 | 0.452 |
| MOD_Plk_1 | 213 | 219 | PF00069 | 0.487 |
| MOD_Plk_1 | 7 | 13 | PF00069 | 0.306 |
| MOD_Plk_1 | 71 | 77 | PF00069 | 0.221 |
| MOD_Plk_4 | 154 | 160 | PF00069 | 0.338 |
| MOD_ProDKin_1 | 269 | 275 | PF00069 | 0.632 |
| MOD_SUMO_rev_2 | 257 | 264 | PF00179 | 0.473 |
| TRG_ENDOCYTIC_2 | 117 | 120 | PF00928 | 0.221 |
| TRG_ENDOCYTIC_2 | 56 | 59 | PF00928 | 0.367 |
| TRG_ER_diArg_1 | 114 | 117 | PF00400 | 0.279 |
| TRG_ER_diArg_1 | 85 | 88 | PF00400 | 0.279 |
| TRG_NLS_Bipartite_1 | 252 | 270 | PF00514 | 0.520 |
| TRG_NLS_MonoCore_2 | 265 | 270 | PF00514 | 0.505 |
| TRG_NLS_MonoExtC_3 | 265 | 270 | PF00514 | 0.511 |
| TRG_NLS_MonoExtN_4 | 263 | 270 | PF00514 | 0.507 |
| TRG_Pf-PMV_PEXEL_1 | 85 | 89 | PF00026 | 0.279 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I6Q3 | Leptomonas seymouri | 85% | 100% |
| A0A0S4KJM6 | Bodo saltans | 70% | 84% |
| A0A1X0NJ23 | Trypanosomatidae | 68% | 95% |
| A0A422P452 | Trypanosoma rangeli | 69% | 100% |
| A4I0N6 | Leishmania infantum | 96% | 100% |
| D0A715 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 70% | 100% |
| E9AWN6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
| O32037 | Bacillus subtilis (strain 168) | 35% | 100% |
| Q46927 | Escherichia coli (strain K12) | 38% | 100% |
| Q4QAT5 | Leishmania major | 96% | 100% |
| Q57097 | Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) | 35% | 100% |
| V5BVX4 | Trypanosoma cruzi | 70% | 84% |